A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
08 2022
Historique:
received: 05 02 2022
accepted: 27 06 2022
entrez: 4 8 2022
pubmed: 5 8 2022
medline: 9 8 2022
Statut: epublish

Résumé

Scrub typhus is a vector-borne febrile illness caused by Orientia tsutsugamushi transmitted by the bite of Trombiculid mites. O. tsutsugamushi has a high genetic diversity and is increasingly recognized to have a wider global distribution than previously assumed. We evaluated the clinical outcomes and host immune responses of the two most relevant human pathogenic strains of O. tsutsugamushi; Karp (n = 4) and Gilliam (n = 4) in a time-course study over 80 days post infection (dpi) in a standardized scrub typhus non-human primate rhesus macaque model. We observed distinct features in clinical progression and immune response between the two strains; Gilliam-infected macaques developed more pronounced systemic infection characterized by an earlier onset of bacteremia, lymph node enlargement, eschar lesions and higher inflammatory markers during the acute phase of infection, when compared to the Karp strain. C-reactive protein (CRP) plasma levels, interferon gamma (IFN-γ, interleukin-1 receptor antagonist (IL-1ra), IL-15 serum concentrations, CRP/IL10- and IFN-γ/IL-10 ratios correlated positively with bacterial load in blood, implying activation of the innate immune response and preferential development of a T helper-type 1 immune response. The O. tsutsugamushi-specific immune memory responses in cells isolated from skin and lymph nodes at 80 dpi were more markedly elevated in the Gilliam-infected macaques than in the Karp-infected group. The comparative cytokine response dynamics of both strains revealed significant up-regulation of IFN-γ, tumor necrosis factor (TNF), IL-15, IL-6, IL-18, regulatory IL-1ra, IL-10, IL-8 and granulocyte-colony-stimulating factor (G-CSF). These data suggest that the clinical outcomes and host immune responses to scrub typhus could be associated with counter balancing effects of pro- and anti-inflammatory cytokine-mediated responses. Currently, no data on characterized time-course comparisons of O. tsutsugamushi strains regarding measures of disease severity and immune response is available. Our study provides evidence for the strain-specificity of host responses in scrub typhus, which supports our understanding of processes at the initial inoculation site (eschar), systemic disease progression, protective and/or pathogenic host immune mechanisms and cellular immune memory function. This study characterised an improved intradermal rhesus macaque challenge model for scrub typhus, whereby the Gilliam strain infection associated with higher disease severity in the rhesus macaque model than the previous Karp strain infection. Difficulties associated with inoculum quantitation for obligate-intracellular bacteria were overcome by using functional inoculum titrations in outbred mice. The Gilliam-based rhesus macaque model provides improved endpoint measurements and contributes towards the identification of correlates of protection for future vaccine development.

Sections du résumé

BACKGROUND
Scrub typhus is a vector-borne febrile illness caused by Orientia tsutsugamushi transmitted by the bite of Trombiculid mites. O. tsutsugamushi has a high genetic diversity and is increasingly recognized to have a wider global distribution than previously assumed.
METHODOLOGY/PRINCIPLE FINDINGS
We evaluated the clinical outcomes and host immune responses of the two most relevant human pathogenic strains of O. tsutsugamushi; Karp (n = 4) and Gilliam (n = 4) in a time-course study over 80 days post infection (dpi) in a standardized scrub typhus non-human primate rhesus macaque model. We observed distinct features in clinical progression and immune response between the two strains; Gilliam-infected macaques developed more pronounced systemic infection characterized by an earlier onset of bacteremia, lymph node enlargement, eschar lesions and higher inflammatory markers during the acute phase of infection, when compared to the Karp strain. C-reactive protein (CRP) plasma levels, interferon gamma (IFN-γ, interleukin-1 receptor antagonist (IL-1ra), IL-15 serum concentrations, CRP/IL10- and IFN-γ/IL-10 ratios correlated positively with bacterial load in blood, implying activation of the innate immune response and preferential development of a T helper-type 1 immune response. The O. tsutsugamushi-specific immune memory responses in cells isolated from skin and lymph nodes at 80 dpi were more markedly elevated in the Gilliam-infected macaques than in the Karp-infected group. The comparative cytokine response dynamics of both strains revealed significant up-regulation of IFN-γ, tumor necrosis factor (TNF), IL-15, IL-6, IL-18, regulatory IL-1ra, IL-10, IL-8 and granulocyte-colony-stimulating factor (G-CSF). These data suggest that the clinical outcomes and host immune responses to scrub typhus could be associated with counter balancing effects of pro- and anti-inflammatory cytokine-mediated responses. Currently, no data on characterized time-course comparisons of O. tsutsugamushi strains regarding measures of disease severity and immune response is available. Our study provides evidence for the strain-specificity of host responses in scrub typhus, which supports our understanding of processes at the initial inoculation site (eschar), systemic disease progression, protective and/or pathogenic host immune mechanisms and cellular immune memory function.
CONCLUSIONS/SIGNIFICANCE
This study characterised an improved intradermal rhesus macaque challenge model for scrub typhus, whereby the Gilliam strain infection associated with higher disease severity in the rhesus macaque model than the previous Karp strain infection. Difficulties associated with inoculum quantitation for obligate-intracellular bacteria were overcome by using functional inoculum titrations in outbred mice. The Gilliam-based rhesus macaque model provides improved endpoint measurements and contributes towards the identification of correlates of protection for future vaccine development.

Identifiants

pubmed: 35925895
doi: 10.1371/journal.pntd.0010611
pii: PNTD-D-22-00142
pmc: PMC9352090
doi:

Substances chimiques

Cytokines 0
Interleukin 1 Receptor Antagonist Protein 0
Interleukin-15 0
Interleukin-10 130068-27-8
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0010611

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT100174/Z/12/Z
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

World J Gastroenterol. 2012 Sep 28;18(36):5138-41
pubmed: 23049227
Southeast Asian J Trop Med Public Health. 1975 Dec;6(4):477-82
pubmed: 818716
Trop Med Infect Dis. 2021 Jul 02;6(3):
pubmed: 34287349
J Immunol. 2018 Feb 15;200(4):1233-1240
pubmed: 29431689
J Infect Dis. 1981 Apr;143(4):558-61
pubmed: 6787140
Microb Pathog. 2006 Jan;40(1):1-7
pubmed: 16325368
J Emerg Trauma Shock. 2012 Apr;5(2):149-52
pubmed: 22787345
Microbiol Immunol. 1996;40(10):743-7
pubmed: 8981347
PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005846
pubmed: 28892515
PLoS Negl Trop Dis. 2017 Jul 27;11(7):e0005815
pubmed: 28750012
Trop Med Int Health. 2019 Dec;24(12):1455-1464
pubmed: 31660667
PLoS One. 2019 Aug 30;14(8):e0221588
pubmed: 31469878
Tuberculosis (Edinb). 2007 Jul;87(4):279-87
pubmed: 17532265
PLoS Negl Trop Dis. 2014 Feb 06;8(2):e2648
pubmed: 24516677
PLoS Negl Trop Dis. 2017 Jul 19;11(7):e0005763
pubmed: 28723951
J Infect Dis. 1997 May;175(5):1142-52
pubmed: 9129078
Microbiol Immunol. 1994;38(9):703-11
pubmed: 7854211
Infect Immun. 1978 Feb;19(2):583-8
pubmed: 415980
J Invest Dermatol. 2016 Jul;136(7):1398-1407
pubmed: 26921773
Int J Mol Sci. 2018 Jun 19;19(6):
pubmed: 29921749
PLoS Negl Trop Dis. 2016 Jun 01;10(6):e0004723
pubmed: 27248711
PLoS Negl Trop Dis. 2018 May 31;12(5):e0006477
pubmed: 29852003
Vaccine. 2003 Nov 7;21(31):4550-4
pubmed: 14575767
mBio. 2022 Feb 8;:e0291821
pubmed: 35130729
Emerg Infect Dis. 2011 Sep;17(9):1659-63
pubmed: 21888791
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
Int J Infect Dis. 2010 Apr;14(4):e328-33
pubmed: 19699129
J Infect Dis. 1973 Aug;128(2):223-6
pubmed: 4198721
J Med Assoc Thai. 2007 Nov;90(11):2366-9
pubmed: 18181321
Infect Immun. 1976 Jul;14(1):39-46
pubmed: 820646
Am J Trop Med Hyg. 2013 Aug;89(2):301-7
pubmed: 23926142
Front Immunol. 2018 Sep 04;9:2022
pubmed: 30233599
Mol Immunol. 2017 Aug;88:138-147
pubmed: 28644973
PLoS Negl Trop Dis. 2015 Aug 14;9(8):e0003971
pubmed: 26274584
J Immunol. 2015 Feb 15;194(4):1702-16
pubmed: 25601925
Vector Borne Zoonotic Dis. 2017 Apr;17(4):260-267
pubmed: 28055333
J Immunol. 1998 Feb 15;160(4):1666-76
pubmed: 9469423
Nat Commun. 2020 Jul 3;11(1):3363
pubmed: 32620750
J Immunol. 2006 Jul 1;177(1):234-45
pubmed: 16785519
Lab Anim Sci. 1986 Oct;36(5):481-5
pubmed: 3534444
Hum Immunol. 2019 Jul;80(7):503-509
pubmed: 30904436
Am J Trop Med Hyg. 2020 Jan;102(1):63-68
pubmed: 31769398
J Infect Dis. 1976 Aug;134(2):193-7
pubmed: 823272
Risk Manag Healthc Policy. 2014 Feb 18;7:29-34
pubmed: 24600256
BMC Infect Dis. 2019 Mar 25;19(1):283
pubmed: 30909868
J Clin Invest. 2003 Jun;111(12):1805-12
pubmed: 12813013
Am J Trop Med Hyg. 2004 Apr;70(4):351-6
pubmed: 15100446
Clin Vaccine Immunol. 2011 Jun;18(6):1021-7
pubmed: 21508168
J Infect Dis. 1977 Apr;135(4):664-8
pubmed: 404364
PLoS Negl Trop Dis. 2014 Sep 25;8(9):e3191
pubmed: 25254971
PLoS Negl Trop Dis. 2018 Mar 9;12(3):e0006305
pubmed: 29522521
PLoS Negl Trop Dis. 2017 Mar 1;11(3):e0005408
pubmed: 28248956
Jpn J Med Sci Biol. 1979 Dec;32(6):345-51
pubmed: 120902
Trop Med Infect Dis. 2018 Jan 17;3(1):
pubmed: 30274407
J Clin Microbiol. 2011 Jul;49(7):2584-9
pubmed: 21593255
J Infect Dis. 2018 Oct 20;218(11):1813-1821
pubmed: 29982731
Trop Med Infect Dis. 2018 Jan 25;3(1):
pubmed: 30274409
PLoS One. 2013;8(1):e54570
pubmed: 23342173
Clin Microbiol Infect. 2012 Dec;18(12):1221-8
pubmed: 22192733
Mod Pathol. 2001 Aug;14(8):752-9
pubmed: 11504834
FEMS Immunol Med Microbiol. 2008 Apr;52(3):335-42
pubmed: 18312580
Pak J Med Sci. 2015 Mar-Apr;31(2):295-9
pubmed: 26101478
J Interferon Cytokine Res. 1999 Feb;19(2):91-104
pubmed: 10090394
J Clin Microbiol. 2010 Dec;48(12):4404-9
pubmed: 20926708
J Clin Microbiol. 2009 Mar;47(3):586-9
pubmed: 19144812
Risk Manag Healthc Policy. 2013 Oct 11;6:43-9
pubmed: 24235852
PLoS Negl Trop Dis. 2017 Sep 25;11(9):e0005838
pubmed: 28945755
Annu Rev Immunol. 1999;17:19-49
pubmed: 10358752
Microbiol Immunol. 2001;45(6):439-46
pubmed: 11497219

Auteurs

Manutsanun Inthawong (M)

Department of Veterinary Medicine, United States Army Medical Directorate, Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS), Bangkok, Thailand.
Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Piyanate Sunyakumthorn (P)

Department of Veterinary Medicine, United States Army Medical Directorate, Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS), Bangkok, Thailand.

Sirima Wongwairot (S)

Department of Veterinary Medicine, United States Army Medical Directorate, Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS), Bangkok, Thailand.
Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Tippawan Anantatat (T)

Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, United States of America.

Susanna J Dunachie (SJ)

Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.

Rawiwan Im-Erbsin (R)

Department of Veterinary Medicine, United States Army Medical Directorate, Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS), Bangkok, Thailand.

James W Jones (JW)

Department of Veterinary Medicine, United States Army Medical Directorate, Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS), Bangkok, Thailand.

Carl J Mason (CJ)

Department of Veterinary Medicine, United States Army Medical Directorate, Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS), Bangkok, Thailand.

Luis A Lugo (LA)

Department of Veterinary Medicine, United States Army Medical Directorate, Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS), Bangkok, Thailand.

Stuart D Blacksell (SD)

Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.

Nicholas P J Day (NPJ)

Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.

Piengchan Sonthayanon (P)

Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Allen L Richards (AL)

Viral & Rickettsial Diseases Department, Naval Medical Research Center, Silver Spring, Maryland, United States of America.
Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.

Daniel H Paris (DH)

Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.
Department of Medicine, Swiss Tropical and Public Health Institute, Faculty of Medicine, University of Basel, Switzerland.
Department of Clinical Research, Faculty of Medicine, University of Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH